126 related articles for article (PubMed ID: 9500559)
21. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
Wörner W; Pfleiderer S; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
[TBL] [Abstract][Full Text] [Related]
22. Dietary intakes by levels of glycemic control for black and white adults with non-insulin dependent diabetes mellitus (NIDDM).
Bell RA; Summerson JH; Konen JC
J Am Coll Nutr; 1995 Apr; 14(2):144-51. PubMed ID: 7790688
[TBL] [Abstract][Full Text] [Related]
23. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
24. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro.
Assert R; Scherk G; Bumbure A; Pirags V; Schatz H; Pfeiffer AF
Diabetologia; 2001 Feb; 44(2):188-95. PubMed ID: 11270675
[TBL] [Abstract][Full Text] [Related]
25. Incidence of non-insulin-dependent diabetes mellitus and its risk factors in Japanese-Americans living in Hawaii and Los Angeles.
Hara H; Egusa G; Yamakido M
Diabet Med; 1996 Sep; 13(9 Suppl 6):S133-42. PubMed ID: 8894497
[TBL] [Abstract][Full Text] [Related]
26. Qualitative platelet 12-lipoxygenase abnormality in a patient with essential thrombocythemia.
Tomo K; Takayama H; Kaneko Y; Fujita J; Nakamura M; Ueda N; Yamamoto S; Okuma M
Thromb Haemost; 1997 Feb; 77(2):294-7. PubMed ID: 9157584
[TBL] [Abstract][Full Text] [Related]
27. Economic evaluation of alternative indicators for screening for diabetes mellitus.
Shirasaya K; Miyakawa M; Yoshida K; Takahashi E; Shimada N; Kondo T
Prev Med; 1999 Aug; 29(2):79-86. PubMed ID: 10446032
[TBL] [Abstract][Full Text] [Related]
28. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
[TBL] [Abstract][Full Text] [Related]
29. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
[TBL] [Abstract][Full Text] [Related]
30. Salicylates and 12-lipoxygenase activity in human washed platelets.
Radomski M; Michalska Z; Marcinkiewicz E; Gryglewski RJ
Pharmacol Res Commun; 1986 Nov; 18(11):1015-30. PubMed ID: 3797446
[TBL] [Abstract][Full Text] [Related]
31. Adipose tissue 12/15 lipoxygenase pathway in human obesity and diabetes.
Lieb DC; Brotman JJ; Hatcher MA; Aye MS; Cole BK; Haynes BA; Wohlgemuth SD; Fontana MA; Beydoun H; Nadler JL; Dobrian AD
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1713-20. PubMed ID: 24955608
[TBL] [Abstract][Full Text] [Related]
32. The effect of acute (60 minute) insulin stimulation upon human skeletal muscle glycogen synthase and protein phosphatase-1 in non-insulin-dependent diabetic patients and control subjects.
Barriocanal LA; Borthwick AC; Stewart M; Wells A; Hurel SJ; Yeaman SJ; Taylor R
Diabet Med; 1995 Dec; 12(12):1110-5. PubMed ID: 8750222
[TBL] [Abstract][Full Text] [Related]
33. Stimulation by carrageenan of arachidonate 12-lipoxygenase activity in dog gingival tissue.
Tamai K; Dohi T; Yoshino H; Shirakawa M; Okamoto H; Tsujimoto A
Arch Oral Biol; 1991; 36(12):913-7. PubMed ID: 1768233
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
Kreugel G; Keers JC; Kerstens MN; Wolffenbuttel BH
Diabetes Technol Ther; 2011 Jul; 13(7):737-41. PubMed ID: 21476936
[TBL] [Abstract][Full Text] [Related]
35. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients.
Rabini RA; Galassi R; Fumelli P; Dousset N; Solera ML; Valdiguie P; Curatola G; Ferretti G; Taus M; Mazzanti L
Diabetes; 1994 Jul; 43(7):915-9. PubMed ID: 8013757
[TBL] [Abstract][Full Text] [Related]
36. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis.
Trenti T; Cristani A; Cioni G; Pentore R; Mussini C; Ventura E
Ric Clin Lab; 1990; 20(4):261-7. PubMed ID: 2075378
[TBL] [Abstract][Full Text] [Related]
37. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
38. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.
Baron AD; Laakso M; Brechtel G; Edelman SV
J Clin Invest; 1991 Apr; 87(4):1186-94. PubMed ID: 2010535
[TBL] [Abstract][Full Text] [Related]
39. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
Yamanouchi T; Moromizato H; Shinohara T; Minoda S; Miyashita H; Akaoka I
Metabolism; 1992 Aug; 41(8):862-7. PubMed ID: 1640864
[TBL] [Abstract][Full Text] [Related]
40. Cytosolic Ca profile of resting and thrombin-stimulated platelets from black women with NIDDM.
Zentay Z; Raguwanshi M; Reddi A; Lasker N; Dasmahapatra A; Aviv A
J Diabetes Complications; 1995; 9(2):74-80. PubMed ID: 7599351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
